BioCryst Pharmaceuticals
BCRX • NASDAQ • Stock Fundamentals
BioCryst Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Charles K. Gayer, with a market cap of $2.3B.
Market Cap$2.3B
Employees531.0
CEOCharles K. Gayer
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 6 days agoQ1 2026
View reportNext EarningsAug 3, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
BioCryst Pharmaceuticals FAQ
Common questions about BioCryst Pharmaceuticals
BioCryst Pharmaceuticals (BCRX) has a market capitalization of $2.3B and trades on NASDAQ.
BioCryst Pharmaceuticals has approximately 531 employees.